125 related articles for article (PubMed ID: 12972024)
1. The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlation.
Brautbar A; Elstein D; Abrahamov A; Zeigler M; Chicco G; Beutler E; Scott CR; Zimran A
Blood Cells Mol Dis; 2003; 31(2):187-9; discussion 190-1. PubMed ID: 12972024
[TBL] [Abstract][Full Text] [Related]
2. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
[TBL] [Abstract][Full Text] [Related]
3. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.
Bronstein S; Karpati M; Peleg L
Isr Med Assoc J; 2014 Nov; 16(11):683-5. PubMed ID: 25558695
[TBL] [Abstract][Full Text] [Related]
4. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
[TBL] [Abstract][Full Text] [Related]
5. Identification of six new Gaucher disease mutations.
Beutler E; Gelbart T; West C
Genomics; 1993 Jan; 15(1):203-5. PubMed ID: 8432537
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of Gaucher disease: distribution of eight mutations and the complete gene deletion in 27 patients from Germany.
le Coutre P; Demina A; Beutler E; Beck M; Petrides PE
Hum Genet; 1997 Jun; 99(6):816-21. PubMed ID: 9187679
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic heterogeneity in patients with Gaucher disease and the N370S/V394L genotype.
Elstein D; Scott CR; Zeigler M; Abrahamov A; Zimran A
Genet Test; 2005; 9(1):26-9. PubMed ID: 15857183
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of 28 Gaucher disease patients: the Australasian experience.
Lewis BD; Nelson PV; Robertson EF; Morris CP
Am J Med Genet; 1994 Jan; 49(2):218-23. PubMed ID: 8116672
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
[TBL] [Abstract][Full Text] [Related]
12. Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.
Aviner S; Garty BZ; Rachmel A; Baris HN; Sidransky E; Shuffer A; Attias J; Yaniv Y; Cohen IJ
Blood Cells Mol Dis; 2009; 43(3):294-7. PubMed ID: 19734074
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease: gene frequencies and genotype/phenotype correlations.
Grabowski GA
Genet Test; 1997; 1(1):5-12. PubMed ID: 10464619
[TBL] [Abstract][Full Text] [Related]
14. Gaucher disease: gene frequencies in the Ashkenazi Jewish population.
Beutler E; Nguyen NJ; Henneberger MW; Smolec JM; McPherson RA; West C; Gelbart T
Am J Hum Genet; 1993 Jan; 52(1):85-8. PubMed ID: 8434610
[TBL] [Abstract][Full Text] [Related]
15. Mutations in Jewish patients with Gaucher disease.
Beutler E; Gelbart T; Kuhl W; Zimran A; West C
Blood; 1992 Apr; 79(7):1662-6. PubMed ID: 1558964
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
17. Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher disease.
Elstein D; Altarescu G; Zimran A
Hematology; 2003 Dec; 8(6):367-8. PubMed ID: 14668030
[TBL] [Abstract][Full Text] [Related]
18. The molecular characterization of Gaucher disease in South Africa.
Morar B; Lane AB
Clin Genet; 1996 Aug; 50(2):78-84. PubMed ID: 8937765
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.
Horowitz M; Tzuri G; Eyal N; Berebi A; Kolodny EH; Brady RO; Barton NW; Abrahamov A; Zimran A
Am J Hum Genet; 1993 Oct; 53(4):921-30. PubMed ID: 8213821
[TBL] [Abstract][Full Text] [Related]
20. Children with type 1 Gaucher disease: Changing profiles in the 21st century.
Elstein D; Altarescu G; Abrahamov A; Zimran A
Blood Cells Mol Dis; 2018 Feb; 68():93-96. PubMed ID: 28185830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
